Introduction
During the last two decades the concept of patient participation has become increasingly important in Danish health care. Patient participation implies that patients are both central objects of health care services, and also agents with particular knowledge and resources, which should be taken into account when decisions about their care are made. Thus, patients are no longer perceived as passive recipients of care, but are expected to engage actively in the management of their disease 1 . Being active partners in health care require that patients are more involved in and responsible for the various processes of their care, including monitoring symptoms, seeking appropriate and timely medical assistance, engaging in dialogue with health professionals, stating their care preferences, and making informed choices (Coulter & Ellins 2006) . Indeed, good clinical practice is increasingly envisioned as a process, in which clinical facts about the disease and its treatment are attuned to the psycho-social background, treatment preferences and illness perceptions of the individual patient. This view is expressed perhaps most strongly in the concept of shared decision making (Coulter & Ellins 2006; Jacobsen, Pedersen, & Albeck 2008; Sheridan, Harris, & Woolf 2004) .
In a report on shared decision making targeting clinicians, Coulter and Collins defines the core of SDM as 'the recognition that clinicians and patients bring different but equally important forms of expertise to the decision-making process' (Coulter & Collins 2011:2) . They explain that the clinician's expertise is based on knowledge of the diagnosis, likely prognosis, treatment and support options, and the range of possible outcomes based on population data. In contrast, patients' expertise consists of their knowledge of how their disease and treatment impact on their daily life, their personal attitude to risk and their values and preferences (Coulter & Collins 2011) . According to Coulter and Collins, shared decision-making implies that both types of expertise are taken into account, and that decisions about treatment and care are reached through agreement and informed by research evidence.
The increasing focus on patient participation, and shared decision making in particular, marks a shift in the conceptualisation of the dialogue with the patient in medicine. Since the late 80's, the ideal communication between doctor and patient has been conceptualised as one of dialogue and involvement, as opposed to one of merely information and consent (Zinck Pedersen 2008) . However, the ideal of dialogue and sharing of equally important forms of knowledge may mask what Grimen (2009) calls 'the nexus of power, trust and risk'; i.e. that patients depend on doctors' professional expertise concerning for instance the risks and benefits of available treatment options and their position as gatekeepers controlling access to treatment, and the inferiority that follows from this dependence (Grimen 2009 ).
Much in line with this critique, qualitative studies have documented a number of patient-related barriers to shared decision making. Among these are patients' expectations to the clinical encounter; for instance some patients believe that 'normal' patients are mostly passive and receiving, and that clinical decisions should be based only on the expert knowledge of the clinician; others believe the way to get high-quality treatment is to get the doctor on their side by being 'good patients', who do not take up too much of the doctors' time or challenge their authority (Joseph-Williams et al. 2014) .
Patients with chronic disease often gain detailed insights about their disease and treatment. These insights span the experience of living with and managing chronic disease, the experience of disease progression and their body's response to medication. In the process they often learn how to interpret medical information relevant to their condition. Thus, the knowledge they glean from their situation is subjective, but they often also gain significant insight into biomedical knowledge about their disease and medication, which may be highly relevant in the clinical encounter. This article describes the conflicts which sometimes occur when patients with chronic disease attempt to participate in decision making about pharmacological treatment, i.e. the domain at the heart of clinicians' expertise. Thus it contributes to current discussions on shared decision making and the barriers for its implementation (Elwyn et al. 2013) . It argues that there is a need for creating a legitimate space for patients' knowledge about their medication in clinical consultations in order to avoid conflicts over knowledge domains, which can otherwise become barriers to the realisation of patient involvement in general and shared decision making in particular.
Methods
The empirical background for this article is three qualitative studies about patient-centred health care in Danish hospitals: A study on shared decision-making in heart rehabilitation and arthritis care (Jacobsen et al. 2008 ); a study on the implementation of patient participation in everyday clinical practice among patients and their relatives in a neurology department (Jacobsen & Petersen 2009) ; and a study on the experience of continuity of care among patients with diabetes, cancer and heart disease (Martin 2010 ).
Data from the three studies comprised observations during consultations, ward rounds, waiting time etc., as well as interviews and/or focus groups with patients and health professionals about their experiences with patient participation. A total of 45 patients and 23 health care professionals were interviewed in the three studies. In addition, 35 health professionals participated in focus groups in the study by Martin (2010) . For the purpose of this article, we present three rich individual cases, illuminating central themes in the data. Each case illustrates an encounter between a patient and health professionals involved in their treatment.
Although the diseases and situations of the patients varied, the cases represent different ways in which patients employ knowledge about their disease and/or medication in the clinical encounter.
Cases Case 1: When patient knowledge is withheld
Peter is in his 60s and has suffered from Parkinson's disease for more than 10 years. He recently had a heart attack and was subsequently diagnosed with ischemic heart disease. He takes medication to control the symptoms of Parkinson (mainly body stiffness and pains in muscles and joints), and to prevent another heart attack (an anti-coagulant called Warafin). Peter is admitted for surgery to have an intestinal medicine infusion pump which can dose his Parkinson medication more precisely. He arrives at the ward in the morning and sees the surgeon for his admission consultation. After reading his journal and asking Peter, the surgeon realises that Peter is still taking Warafin. Anti-coagulants increase the risk of serious bleeding and is contraindicated before an operation. The operation is therefore postponed until the effect of the drug has worn off. Peter is kept on the ward, as the health professionals assume that he will be ready for operation the following day. However, it proves difficult to estimate exactly when the effect of the medication has worn off, and the operation is postponed three times. Each time Peter has to fast and is told not to take his Parkinson medication. Consequently, the planned operation causes Peter's Parkinson symptoms to flare up, with the result that he is in great pain for some time. The staff and Peter have different opinions as to who is to blame for this situation: A nurse talking to her colleagues blames Peter for 'being so forgetful', and not telling the doctor about his medication well in advance of the planned operation. When the nurse is measuring his blood pressure, Peter blames the doctor for having forgotten about the Warafin. But as the nurse leaves, Peter says to himself and the researcher besides him: "I knew it. I did. But I didn't want to interfere in their affairs. I didn't want to play the doctor."
Peter's last comment tells us that there is more at stake than simple lapse of memory. Peter was aware that Warafin should not be taken before an operation. In the interview later on he blames himself for not having asked the doctor about the Warafin before he was admitted for the operation.
Peter: "I should not have taken Warafin, but I didn't want to ask" (continues in a feigned childish voice): 'should I then continue with Warafin?'"
Interviewer: "So you had thought about it?
Peter: "Yes, of course, you can't even go to the dentist when taking Warafin."
Peter points to an important issue. He suggests that it may be considered inappropriate for patients to bring forth their knowledge if it interferes with the doctor's professional knowledge.
Peter mimics a child's voice as he poses the question he never asked during the consultation. His imitation defines the child's position as one of ignorance and submission. Although Peter has years of experience with his disease and his medication, he does not want to 'play the doctor' and claim authority, but refrains from voicing his concern. By not mentioning Warafin, Peter acknowledges the exclusive right of the doctor to possess and act upon biomedical knowledge, and assumes that his participation would be an undue interference with the doctor's professional domain.
Strauss et al. have claimed that health professionals continuously judge the actions of their patients (Strauss, Fagerhaugh, Suczek, & Wiener 1997) . They may see patients' 'work' 2 as good or bad, rational or irrational, sensible or foolish etc.
As Peter's case illustrates, patients are aware of this judgement of their actions, and they assume that the health care professionals perceive them as 'good' or 'bad' patients, depending on how they behave. Therefore, many patients endeavour to communicate in a way they think will minimize conflict and maintain a good relationship with the health professionals. In line with Grimen's point that the power of doctors is related to access to treatment, many of the patients who participated in the three research studies believed that they would obtain better treatment if the health professionals viewed them in a positive light. Behaving as a good patient, i.e. as they thought the health professionals expected them to act, therefore became an important strategy.
Peter's case illustrates that the separation of clinicians' and patients' areas of expertise are, at least in part, instigated and reproduced by patients. This can be seen as an example of collusion -a tacit, sometimes not quite conscious, agreement between different actors to behave and communicate in ways that maintain the social order and avoid any behaviour or statements that would break it. In the case above, Peter makes sure that he does not challenge the doctor's position as biomedical expert, and acts in a way he assumes is considered appropriate in a hospital:
the cooperative patient who commits himself fully to hospital care. In this way, potential conflict is avoided and social order is maintained. Unfortunately, this order comes at a cost. Peter is frustrated with the way preparations for his surgery took place, which he sees as partly his own fault. Indeed, his case represents the unfortunate consequences of this submissive approach: because of his unwillingness 'to interfere' he had to endure a week of pains and disappointment.
Case 2: When patient knowledge is disregarded Jane, a woman in her 40s, has had diabetes (type I) for 25 years. She takes her disease very seriously and carefully manages her blood sugar levels. At the time of the interview she had been admitted to hospital for four days to undergo reconstructive surgery of a painful scar in the groin. During the interview, it becomes clear that although the clinical staff was nice and efficient, she found that their management of her insulin injections during her admittance was below standard. Administering insulin is a daily task for type 1 diabetics. People who live with diabetes for many years acquire extensive factual and experiential knowledge about their condition, its treatment, and how their body responds to it. Jane, who has had diabetes for 25 years, is an expert on her condition, and has been encouraged to think of herself that way at the biannual check-ups with her endocrinologist. Her willingness to take responsibility is something she emphasizes in the interview.
However, her knowledge is not recognised by the health professionals in the surgery department. Instead, they take over the glycaemic control of diabetic patients and follow a generic schedule for insulin injections. This is standard procedure when patients with diabetes are admitted to the department. In the interview, Jane recounts how she has initial doubts about the quality of this treatment approach, but that she also acknowledges the medical authority of the doctors and nurses she meets and therefore surrenders control of her diabetes to them. Jane's case illustrates that the ideal of the active, responsible patient may not be compatible with the reality of decision making in all medical areas and situations.
The active patient role advocated in the principle of patient participation applies easily to an outpatient department where treatment and care is centred around patients' self-management of their condition. But the institutional framework of the surgery department contributes to the passivity of diabetic patients by encouraging them to give up responsibility for the medication management.
Jane is keen to present herself as a 'strong patient', who is not afraid to voice her needs when talking to health care professionals and who knows how to obtain the services she considers necessary for her treatment. As such, she is indeed a good example of the active patient. Unlike Peter, she expresses her opinion about her treatment and care, and is not afraid to point out failures or suggest procedural changes to both nurses and doctors. Yet at the same time, she emphasizes that her aim is not to complain, but simply to get help in her pursuit of care, and that she has always been very friendly and tried not to annoy the doctors. By acting this way, she pursues two strategies simultaneously: 1) She takes responsibility, asserts her needs and presents her perspective, while also 2) acknowledging an institutional hierarchy in which the patient is dependent on the health professionals and thereby constitutes the lowest level. These two strategies allow Jane to simultaneously maintain and challenge the social order that defines the doctor as the knowledgeable authority and the patient as passive and 'unknowing'.
Case 3: When patient knowledge leads to conflict
The last case is from an arthritis outpatient clinic. Arthritis cannot be cured and so treatment is focused on controlling symptoms, i.e. reducing pain and minimizing the deterioration of bones and joints. When symptoms and objective disease markers change and warrants adjustments of medication, patient knowledge and professional knowledge needs to be exchanged. Blood tests, scans and mobility tests are employed to obtain an overview of symptoms and make decisions about medication. But patients' subjective evaluations of pain and the effect of the treatment contribute crucial information to the process of medical decision-making.
However, if the boundaries between knowledge domains become blurred this exchange may become conflictual. This was the case in the consultation with Bettina who is a middle-aged woman who has been treated for arthritis in the clinic for a couple of years. Prior to the consultation, the researcher observes the doctor preparing for the consultation. The doctor reads the patient file and notes that Bettina does not receive the clinic's first-choice treatment. The doctor consults her colleague who encourages her to change the patient's treatment. During the consultation, the doctor tries to persuade Bettina to change medication: It is clear from this quote that Bettina has a strong preference for the medicine she takes, and she argues her case by referring to clinical factors such as her blood test results rather than her personal experience of pain or side effects. The doctor deflects Bettina's knowledge of blood tests by referring to the importance of other clinical information -ultrasound scans and soreness of joints -which only the doctor can interpret. Bettina demands that the decision is made on the basis of test results rather than the doctor's assessment. The atmosphere during the consultation grows tense. Not only the dialogue, but also gestures, facial expression and tone of voice indicate that there is a conflict over the choice of medication.
After the consultation the doctor explains to the researcher that she thinks it is problematic, when patients think they have expert knowledge, because managing arthritis is a very complex and demanding field even for doctors who specialize in it. The doctor sees Bettina's unwillingness to change medication as an irrational fear of the side-effects of cytotoxic drugs, which many patients know are also used in cancer treatment (i.e. chemotherapy And also, when my colleagues ask why she is given Salazopyrin… I will have to write in the journal that it was HER choice and that she does not want the Methrotrexate treatment even though we all know she ought to have it … She is typical for the patients who are difficult to get involved because she is so prejudiced."
The example illustrates that this particular patient is considered 'trespassing' when she states her treatment preferences with reference to clinical knowledge.
It also illustrates the lack of agreement about what patient participation and dialogue is in practice. While the doctor agrees that patient participation is legitimate to this type of consultation, she seems to be expecting a kind of participation which is similar to a more traditional paternalistic approach to clinical decisionmaking. She expects that when she puts forward her opinion on the right choice of medication, the patient will accept this as the right choice. Similar findings are described by Stone (1997) If patients' clinical knowledge is to have a place in the doctor-patient communication, doctors will have to actively invite them to disclose this knowledge. As our cases show, patients may be very reluctant to venture into clinical territory.
One step towards this goal could be a widening of the notion of shared decision making to extend the concept of partnership to encompass the extensive clinical knowledge that some patients with chronic disease acquire over time. Seeing the doctor and patient as partners does not mean that their roles are interchangeable or their knowledge the same. In its ideal sense, the concept of partnership implies a respectful dialogue that includes the knowledge and perspectives of both patient and health professional. Seen this way, the question of 'who knows best' may be less relevant. Instead we should start asking 'how can doctors -expertise and authority intact -make space for the full breadth of patient knowledge? With the ultimate goal of better treatment.
the patients and the health professionals who took time to talk to us in all three studies, and to Anja Petersen, who collected the case about Peter as she took part in one of the original studies.
Notes 1: Another aspect of patient participation concerns the evaluation and improvement of health care delivery through the monitoring of patient satisfaction with the services they encounter (Coulter & Ellins 2006 ) 2: Strauss terms all the actions of patients in relation to treatment as 'work' and considers this comparable to the work of health professionals. 3: 'Hypo' is short for hypoglycaemic episode. 4: Methotraxate is used in high doses in cancer treatment, but also in low doses when treating for instance arthritis. It is usually well tolerated in low doses, while adverse drug reactions (incl., nausea, vomiting, diarrhea and fatigue) are more common in high doses.
